×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Germline mutation of ARF in a melanoma kindred.
12019208
2002
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families.
11506491
2001
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
10874641
1999
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
9425228
1998
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Five novel somatic CDKN2/p16 mutations identified in melanoma, glioma and carcinoma of the pancreas. Mutations in brief no. 170. Online.
10651484
1998
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Germline mutations of the CDKN2 gene in UK melanoma families.
9328469
1997
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
8710906
1996
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
8653684
1996
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.
8595405
1995
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
GeneticVariation
UNIPROT
Germline p16 mutations in familial melanoma.
7987387
1994
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Squamous cell carcinoma
0.700
GeneticVariation
UNIPROT
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Cutaneous Melanoma
0.700
CausalMutation
CGI
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Cutaneous Melanoma
0.700
GenomicAlterations
CGI
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
0.700
Biomarker
CTD_human
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
CTD_human
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
27064257
2016
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
CTD_human
Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
16317707
2005
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
CTD_human
Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
12378512
2002
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Melanoma astrocytoma syndrome
0.610
GeneticVariation
ORPHANET
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.
11136714
2001
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Melanoma astrocytoma syndrome
0.610
Biomarker
CTD_human
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Childhood Acute Lymphoblastic Leukemia
0.600
Biomarker
GENOMICS_ENGLAND
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia .
27756164
2017
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Malignant neoplasm of pancreas
0.600
Biomarker
CTD_human
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
26098869
2015
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA-PANCREATIC CANCER SYNDROME
0.600
Biomarker
CLINGEN
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
22636603
2012
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Non-Small Cell Lung Carcinoma
0.600
Biomarker
CTD_human
This study suggests that P16/CDKN2A gene inactivation in asbestos-exposed NSCLC cases mainly occurs via deletion, a feature also found in malignant mesothelioma, a tumor independent of tobacco smoking but associated with asbestos exposure, suggesting a possible relationship with an effect of asbestos fibers.
19375815
2010
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Childhood Acute Lymphoblastic Leukemia
0.600
Biomarker
CTD_human
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
20453839
2010
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
MELANOMA-PANCREATIC CANCER SYNDROME
0.600
Biomarker
CLINGEN
Novel and recurrent p14 mutations in Italian familial melanoma.
20132244
2010